MARKETS
Earnings

Organon Says FDA Accepted For Review Sebela's sNDA To Extend MIUDELLA Copper IUD Duration Of Use From 3 To 6 Years; PDUFA Action Expected In Q2 2027

Sep 14, 2026 · 07:35 AM ET· updated 51m ago

Share
Why It Matters

Organon got approval to review a longer-lasting birth control device. Doctors will decide if it works for six years instead of three.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.